Caroline M Greenberg, MD | |
579a Cranbury Rd, East Brunswick, NJ 08816 | |
(732) 390-0040 | |
(732) 390-1856 |
Full Name | Caroline M Greenberg |
---|---|
Gender | Female |
Speciality | Diagnostic Radiology |
Experience | 35 Years |
Location | 579a Cranbury Rd, East Brunswick, New Jersey |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104808310 | NPI | - | NPPES |
02197051 | Medicaid | NY | |
6996507 | Medicaid | NJ |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | 25MA06082800 (New Jersey) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Hunterdon Medical Center | Flemington, NJ | Hospital |
Saint Peter's University Hospital | New brunswick, NJ | Hospital |
Robert Wood Johnson University Hospital | New brunswick, NJ | Hospital |
St Luke's Warren Hospital | Phillipsburg, NJ | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Flemington Radiology Associates Llc | 5294145819 | 55 |
University Radiology Group Llc | 6608868500 | 213 |
University Radiology At Robert Wood Johnson, Llc | 7810052388 | 120 |
News Archive
OSI Systems, Inc., a vertically-integrated provider of specialized electronic products for critical applications in the Security and Healthcare industries, today announced that its Healthcare division, Spacelabs Healthcare, has received a contract from Thomas Memorial Hospital in Charleston, West Virginia for a broad range of patient monitoring products.
VIVUS, Inc. today announced positive results from a phase 2 study evaluating the safety and efficacy of Qnexa®, an investigational drug, for the treatment of obstructive sleep apnea (OSA). VIVUS recently completed phase 3 development of Qnexa for the treatment of obesity and submitted a New Drug Application (NDA) to the FDA for that indication.
A new study provides direct evidence that the oligosaccharides attached to the viral surface spike protein are essential for viral infection, offering new approaches to preventive and therapeutic drugs.
California Gov. Jerry Brown warns more budget cuts are coming, and many expect trims to health programs. In the meantime, a bid to reduce funding to federally qualified health centers in the state failed.
The second-most common type of breast cancer is a very different disease than the most common and appears to be a good candidate for a personalized approach to treatment, according to a multidisciplinary team led by scientists at the University of Pittsburgh Cancer Institute (UPCI), a partner with UPMC CancerCenter.
› Verified 5 days ago
Entity Name | University Radiology Group Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1154367803 PECOS PAC ID: 6608868500 Enrollment ID: O20040331001432 |
News Archive
OSI Systems, Inc., a vertically-integrated provider of specialized electronic products for critical applications in the Security and Healthcare industries, today announced that its Healthcare division, Spacelabs Healthcare, has received a contract from Thomas Memorial Hospital in Charleston, West Virginia for a broad range of patient monitoring products.
VIVUS, Inc. today announced positive results from a phase 2 study evaluating the safety and efficacy of Qnexa®, an investigational drug, for the treatment of obstructive sleep apnea (OSA). VIVUS recently completed phase 3 development of Qnexa for the treatment of obesity and submitted a New Drug Application (NDA) to the FDA for that indication.
A new study provides direct evidence that the oligosaccharides attached to the viral surface spike protein are essential for viral infection, offering new approaches to preventive and therapeutic drugs.
California Gov. Jerry Brown warns more budget cuts are coming, and many expect trims to health programs. In the meantime, a bid to reduce funding to federally qualified health centers in the state failed.
The second-most common type of breast cancer is a very different disease than the most common and appears to be a good candidate for a personalized approach to treatment, according to a multidisciplinary team led by scientists at the University of Pittsburgh Cancer Institute (UPCI), a partner with UPMC CancerCenter.
› Verified 5 days ago
Entity Name | University Radiology Group Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1154367803 PECOS PAC ID: 6608868500 Enrollment ID: O20040501000035 |
News Archive
OSI Systems, Inc., a vertically-integrated provider of specialized electronic products for critical applications in the Security and Healthcare industries, today announced that its Healthcare division, Spacelabs Healthcare, has received a contract from Thomas Memorial Hospital in Charleston, West Virginia for a broad range of patient monitoring products.
VIVUS, Inc. today announced positive results from a phase 2 study evaluating the safety and efficacy of Qnexa®, an investigational drug, for the treatment of obstructive sleep apnea (OSA). VIVUS recently completed phase 3 development of Qnexa for the treatment of obesity and submitted a New Drug Application (NDA) to the FDA for that indication.
A new study provides direct evidence that the oligosaccharides attached to the viral surface spike protein are essential for viral infection, offering new approaches to preventive and therapeutic drugs.
California Gov. Jerry Brown warns more budget cuts are coming, and many expect trims to health programs. In the meantime, a bid to reduce funding to federally qualified health centers in the state failed.
The second-most common type of breast cancer is a very different disease than the most common and appears to be a good candidate for a personalized approach to treatment, according to a multidisciplinary team led by scientists at the University of Pittsburgh Cancer Institute (UPCI), a partner with UPMC CancerCenter.
› Verified 5 days ago
Entity Name | University Radiology At Trinitas Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1366526279 PECOS PAC ID: 9133174634 Enrollment ID: O20050317000492 |
News Archive
OSI Systems, Inc., a vertically-integrated provider of specialized electronic products for critical applications in the Security and Healthcare industries, today announced that its Healthcare division, Spacelabs Healthcare, has received a contract from Thomas Memorial Hospital in Charleston, West Virginia for a broad range of patient monitoring products.
VIVUS, Inc. today announced positive results from a phase 2 study evaluating the safety and efficacy of Qnexa®, an investigational drug, for the treatment of obstructive sleep apnea (OSA). VIVUS recently completed phase 3 development of Qnexa for the treatment of obesity and submitted a New Drug Application (NDA) to the FDA for that indication.
A new study provides direct evidence that the oligosaccharides attached to the viral surface spike protein are essential for viral infection, offering new approaches to preventive and therapeutic drugs.
California Gov. Jerry Brown warns more budget cuts are coming, and many expect trims to health programs. In the meantime, a bid to reduce funding to federally qualified health centers in the state failed.
The second-most common type of breast cancer is a very different disease than the most common and appears to be a good candidate for a personalized approach to treatment, according to a multidisciplinary team led by scientists at the University of Pittsburgh Cancer Institute (UPCI), a partner with UPMC CancerCenter.
› Verified 5 days ago
Entity Name | University Radiology At Robert Wood Johnson, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1710131677 PECOS PAC ID: 7810052388 Enrollment ID: O20090217000263 |
News Archive
OSI Systems, Inc., a vertically-integrated provider of specialized electronic products for critical applications in the Security and Healthcare industries, today announced that its Healthcare division, Spacelabs Healthcare, has received a contract from Thomas Memorial Hospital in Charleston, West Virginia for a broad range of patient monitoring products.
VIVUS, Inc. today announced positive results from a phase 2 study evaluating the safety and efficacy of Qnexa®, an investigational drug, for the treatment of obstructive sleep apnea (OSA). VIVUS recently completed phase 3 development of Qnexa for the treatment of obesity and submitted a New Drug Application (NDA) to the FDA for that indication.
A new study provides direct evidence that the oligosaccharides attached to the viral surface spike protein are essential for viral infection, offering new approaches to preventive and therapeutic drugs.
California Gov. Jerry Brown warns more budget cuts are coming, and many expect trims to health programs. In the meantime, a bid to reduce funding to federally qualified health centers in the state failed.
The second-most common type of breast cancer is a very different disease than the most common and appears to be a good candidate for a personalized approach to treatment, according to a multidisciplinary team led by scientists at the University of Pittsburgh Cancer Institute (UPCI), a partner with UPMC CancerCenter.
› Verified 5 days ago
Entity Name | Jersey Shore Imaging Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1538304019 PECOS PAC ID: 1355408212 Enrollment ID: O20090319000362 |
News Archive
OSI Systems, Inc., a vertically-integrated provider of specialized electronic products for critical applications in the Security and Healthcare industries, today announced that its Healthcare division, Spacelabs Healthcare, has received a contract from Thomas Memorial Hospital in Charleston, West Virginia for a broad range of patient monitoring products.
VIVUS, Inc. today announced positive results from a phase 2 study evaluating the safety and efficacy of Qnexa®, an investigational drug, for the treatment of obstructive sleep apnea (OSA). VIVUS recently completed phase 3 development of Qnexa for the treatment of obesity and submitted a New Drug Application (NDA) to the FDA for that indication.
A new study provides direct evidence that the oligosaccharides attached to the viral surface spike protein are essential for viral infection, offering new approaches to preventive and therapeutic drugs.
California Gov. Jerry Brown warns more budget cuts are coming, and many expect trims to health programs. In the meantime, a bid to reduce funding to federally qualified health centers in the state failed.
The second-most common type of breast cancer is a very different disease than the most common and appears to be a good candidate for a personalized approach to treatment, according to a multidisciplinary team led by scientists at the University of Pittsburgh Cancer Institute (UPCI), a partner with UPMC CancerCenter.
› Verified 5 days ago
Entity Name | University Radiology-atlantic, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1477802064 PECOS PAC ID: 6901059864 Enrollment ID: O20130102000114 |
News Archive
OSI Systems, Inc., a vertically-integrated provider of specialized electronic products for critical applications in the Security and Healthcare industries, today announced that its Healthcare division, Spacelabs Healthcare, has received a contract from Thomas Memorial Hospital in Charleston, West Virginia for a broad range of patient monitoring products.
VIVUS, Inc. today announced positive results from a phase 2 study evaluating the safety and efficacy of Qnexa®, an investigational drug, for the treatment of obstructive sleep apnea (OSA). VIVUS recently completed phase 3 development of Qnexa for the treatment of obesity and submitted a New Drug Application (NDA) to the FDA for that indication.
A new study provides direct evidence that the oligosaccharides attached to the viral surface spike protein are essential for viral infection, offering new approaches to preventive and therapeutic drugs.
California Gov. Jerry Brown warns more budget cuts are coming, and many expect trims to health programs. In the meantime, a bid to reduce funding to federally qualified health centers in the state failed.
The second-most common type of breast cancer is a very different disease than the most common and appears to be a good candidate for a personalized approach to treatment, according to a multidisciplinary team led by scientists at the University of Pittsburgh Cancer Institute (UPCI), a partner with UPMC CancerCenter.
› Verified 5 days ago
Entity Name | Flemington Radiology Associates Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1942816475 PECOS PAC ID: 5294145819 Enrollment ID: O20201110000349 |
News Archive
OSI Systems, Inc., a vertically-integrated provider of specialized electronic products for critical applications in the Security and Healthcare industries, today announced that its Healthcare division, Spacelabs Healthcare, has received a contract from Thomas Memorial Hospital in Charleston, West Virginia for a broad range of patient monitoring products.
VIVUS, Inc. today announced positive results from a phase 2 study evaluating the safety and efficacy of Qnexa®, an investigational drug, for the treatment of obstructive sleep apnea (OSA). VIVUS recently completed phase 3 development of Qnexa for the treatment of obesity and submitted a New Drug Application (NDA) to the FDA for that indication.
A new study provides direct evidence that the oligosaccharides attached to the viral surface spike protein are essential for viral infection, offering new approaches to preventive and therapeutic drugs.
California Gov. Jerry Brown warns more budget cuts are coming, and many expect trims to health programs. In the meantime, a bid to reduce funding to federally qualified health centers in the state failed.
The second-most common type of breast cancer is a very different disease than the most common and appears to be a good candidate for a personalized approach to treatment, according to a multidisciplinary team led by scientists at the University of Pittsburgh Cancer Institute (UPCI), a partner with UPMC CancerCenter.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Caroline M Greenberg, MD 579a Cranbury Rd, East Brunswick, NJ 08816 Ph: (732) 390-0040 | Caroline M Greenberg, MD 579a Cranbury Rd, East Brunswick, NJ 08816 Ph: (732) 390-0040 |
News Archive
OSI Systems, Inc., a vertically-integrated provider of specialized electronic products for critical applications in the Security and Healthcare industries, today announced that its Healthcare division, Spacelabs Healthcare, has received a contract from Thomas Memorial Hospital in Charleston, West Virginia for a broad range of patient monitoring products.
VIVUS, Inc. today announced positive results from a phase 2 study evaluating the safety and efficacy of Qnexa®, an investigational drug, for the treatment of obstructive sleep apnea (OSA). VIVUS recently completed phase 3 development of Qnexa for the treatment of obesity and submitted a New Drug Application (NDA) to the FDA for that indication.
A new study provides direct evidence that the oligosaccharides attached to the viral surface spike protein are essential for viral infection, offering new approaches to preventive and therapeutic drugs.
California Gov. Jerry Brown warns more budget cuts are coming, and many expect trims to health programs. In the meantime, a bid to reduce funding to federally qualified health centers in the state failed.
The second-most common type of breast cancer is a very different disease than the most common and appears to be a good candidate for a personalized approach to treatment, according to a multidisciplinary team led by scientists at the University of Pittsburgh Cancer Institute (UPCI), a partner with UPMC CancerCenter.
› Verified 5 days ago
Salim Samuel, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 579a Cranbury Rd, University Radiology Group Pc, East Brunswick, NJ 08816 Phone: 732-390-0040 Fax: 732-390-1856 | |
Jeffrey Dorr, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 483 Cranbury Rd, East Brunswick, NJ 08816 Phone: 732-390-0030 Fax: 732-390-5383 | |
David L Rosenfeld, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 483 Cranbury Rd, University Radiology Group Pc, East Brunswick, NJ 08816 Phone: 732-390-0030 Fax: 732-390-5383 | |
Dr. Levi Olatokunbo Sokol, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 483 Cranbury Rd, East Brunswick, NJ 08816 Phone: 732-390-0040 Fax: 732-390-1856 | |
Stephen William Warren, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 579a Cranbury Rd, University Radiology Group Pc, East Brunswick, NJ 08816 Phone: 732-390-0040 Fax: 732-390-1856 | |
Douglas Mark Solonick, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 579a Cranbury Rd, University Radiology Group Pc, East Brunswick, NJ 08816 Phone: 732-390-0040 Fax: 732-390-1856 | |
Harsha Jonna, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 579a Cranbury Rd, East Brunswick, NJ 08816 Phone: 732-390-0040 Fax: 732-390-1856 |